Allianz Asset Management
OME

Allianz Asset Management’s Omega Protein OME Stock Holding History

Allianz Asset Management’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-472,373
Closed -$7.87M – 2812
2017
Q3 		$7.87M Sell
472,373
-19,881
-4% -$323K 0.01% 1406
2017
Q2 		$8.79M Buy
492,254
+41,409
+9% +$774K 0.01% 1357
2017
Q1 		$9.04M Sell
450,845
-45,171
-9% -$1.05M 0.01% 1371
2016
Q4 		$12.4M Buy
496,016
+83,525
+20% +$1.97M 0.01% 1260
2016
Q3 		$9.64M Sell
412,491
-310,925
-43% -$7.31M 0.01% 1342
2016
Q2 		$14.5M Buy
723,416
+176,218
+32% +$3.29M 0.02% 1073
2016
Q1 		$9.27M Buy
547,198
+137,845
+34% +$2.83M 0.01% 1162
2015
Q4 		$9.23M Buy
+409,353
New +$8.52M 0.01% 1089
2014
Q4 		– Sell
-23,342
Closed -$292K – 2431
2014
Q3 		$292K Buy
23,342
+14,906
+177% +$208K ﹤0.01% 2067
2014
Q2 		$115K Buy
+8,436
New +$110K ﹤0.01% 1861

Allianz Asset Management's OME Position: Q4 2017 in Review

Allianz Asset Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 472,373 shares — an estimated $7.87M sold.

Allianz Asset Management first reported a position in OME in Q2 2014 and held it in 10 quarters. The position peaked at $14.5M in Q2 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Allianz Asset Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Allianz Asset Management sold 472,373 Omega Protein shares in Q4 2017, an estimated $7.87M.
  • Allianz Asset Management first reported a position in Omega Protein in Q2 2014 and held it in 10 quarters.
  • Allianz Asset Management's Omega Protein position peaked at $14.5M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Allianz Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.